Fisch, Daniel https://orcid.org/0000-0002-8155-0367
Ohri, Vaani https://orcid.org/0000-0003-3344-855X
Anastasakou, Eleni https://orcid.org/0000-0002-0606-3382
Wesemann, Lucia J. https://orcid.org/0009-0003-3660-0841
Choi, Joon H. https://orcid.org/0000-0003-4254-0286
Lindblad, Katherine E.
Kagan, Jonathan C. https://orcid.org/0000-0003-2364-2746
Article History
Received: 13 March 2026
Accepted: 17 August 2026
First Online: 23 September 2026
Ethics
Competing interests: J.C.K. receives compensation from and holds equity in Corner Therapeutics, Larkspur Biosciences, MindImmune Therapeutics and Neumora Therapeutics. None of these relationships impacted this study. The other authors declare no competing interests.